ABVC BioPharma's total assets for Q4 2025 were $21.06M, a decrease of -0.54% from the previous quarter. ABVC total liabilities were $7.76M for the fiscal quarter, a 16.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.